Načítá se...
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass
Unfractionated heparin (UFH), the standard anticoagulant for cardiopulmonary bypass (CPB) surgery, carries a risk of post-operative bleeding and is potentially harmful in patients with heparin-induced thrombocytopenia-associated antibodies. To improve the activity of an alternative anticoagulant, th...
Uloženo v:
| Vydáno v: | Nat Biotechnol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6349032/ https://ncbi.nlm.nih.gov/pubmed/29863725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4153 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|